COSM Company Profile and Key Details

Cosmos Health Inc. generated EPS of -$0.71 over the past year. Five-year average earnings growth is 28.41%. Wall Street analysts project EPS growth of 62.88% annually over the next five years. Cosmos Health Inc. earnings surprise history is a mixed track record. The quarter that ended May 21, 2026, missed forecasts by 0.0%. The prior quarter beat by 3200.0%. Over the last six quarters, Apple has recorded several small beats. These include -11.11% in April 15, 2025.

COSM has shown mixed momentum, losing -1.65% over the past week and -52.14% over the past quarter, though year-to-date performance is down -0.54%. Short-term trend indicators are bullishly aligned (SMA20 -5.97%, SMA50 -16.94%, SMA200 -39.65%). The stock’s 14-day RSI is 41.64 (neutral), while the ATR of 0.04 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -70.46% below its high and over 39.2% above its low. Average 10-day trading volume of 10.46 million shares is significantly above the 3-month average of 6.13 million, indicating heightened recent market interest.

Cosmos Health Inc. has 30.21 million shares outstanding. The public float is 20.12 million shares, elevated short interest at 1.91% of float. This equals 442.09 thousand shares. The short ratio is 0.37 days. Institutional investors hold 11.92% of the float. Insiders own 28.16%. Siokas Grigorios holds 13.48 million shares, Terzis Georgios has 2.24 million shares and GOLDSTEIN PETER has 157.10 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Cosmos Health Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.09. This means the shares are trading below this model’s fair value.

Cosmos Health Inc. (NASDAQ:COSM) closed at $0.20 USD, gaining $0.01 (8.07%) from the previous close of $0.18. The stock is currently mid-range between its 52-week high and low $0.16 and $1.32. With a market capitalization of about $12.39 million, Cosmos Health Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~4.12). Key stats such as the average daily volume over the past year has been around 6.27 million shares, in line with its 52-week average. Headquartered in Chicago, IL, Cosmos Health Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Grigorios Siokas, the company employs approximately 149 people and listed since July 23, 2010. Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods.

Cosmos Health Inc. trades at a P/E ratio of -0.29, slightly below the S&P 500 average, with a price-to-sales ratio of 0.17 and a price-to-book ratio of 0.46 suggesting the stock is closer to book value. The P/FCF stands at -1.07, also above market averages.

Our AI price prediction model suggests that Cosmos Health Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -18.79%, with price expected at $0.15 by July 14, 2026, within a range of $0.13 to $0.16 3-Month Outlook: Projected rise of 100.32%, reaching $0.37 by September 28, 2026, with a range of $0.32 to $0.40. 1-Year Outlook: Projected loss of -13.37%, with price at $0.16 by June 30, 2027, within a range of $0.00 to $0.00.

Cosmos Health Inc. (NASDAQ:COSM) shares are flat -0.54% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Cosmos Health Inc. trading at a premium to the broader market with a P/E of -0.29. Our AI forecast model points to short-term weakness (-18.79% over two weeks), a medium-term rise (100.32% over three months), and a longer-term loss (-13.37% over one year), with expected trading ranges indicating moderate volatility.